Taro Pharmaceutical (TARO) Misses Q4 Earnings and Revenue Estimates
Taro (TARO) delivered earnings and revenue surprises of -32.74% and -5.26%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Taro Pharmaceutical (TARO) Misses Q4 Earnings and Revenue Estimates
Taro (TARO) delivered earnings and revenue surprises of -32.74% and -5.26%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?